BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019

Apr 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-04-11

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-11	Common Stock	M	1000	$14.39	Acquired	325211	Direct
2019-04-12	Common Stock	M	4000	$14.39	Acquired	329211	Direct
2019-04-12	Common Stock	S	4000	$89.12	Disposed	325211	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-11	Stock Option (Right to buy Common Stock)	$14.39	M	1000	Disposed	2019-05-11	Common Stock (1000)	Direct
2019-04-12	Stock Option (Right to buy Common Stock)	$14.39	M	4000	Disposed	2019-05-11	Common Stock (4000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	181341	Indirect

Footnotes

F1: This trade is made pursuant to a 10b5-1 plan executed on March 5, 2019.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.